Secondary analysis of the OPTIMUM trial in 347 patients having micro-ultrasound-guided biopsy: PRI-MUS 3–5 detected csPCa with 72% sensitivity and 93% NPV per core (AUC 0.78), and 92% sensitivity and 83% NPV per lesion (AUC 0.78).
Secondary analysisn = 347
Lazarovich et al. External Validation of the PRI-MUS Scoring System: A Secondary Analysis of the OPTIMUM Randomized Controlled Trial